CLX-0921 is an orally active PPARgamma agonist with an IC50 of 1.54 µM. CLX-0921 has a potent antihyperglycemic activity, and can be used for the study of type 2 diabetes[1].
Molecular Weight:
519.57
CAS Number:
[249886-47-3]
Formula:
C28H25NO7S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted